Anzeige
Mehr »
Donnerstag, 22.01.2026 - Börsentäglich über 12.000 News
Gold über 4.862 USD - auf dem Weg zu 5.000 USD: Warum A2 Gold jetzt in eine neue Liga aufsteigt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DVUC | ISIN: NZAFTE0001S4 | Ticker-Symbol:
Branche
Versorger
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AFT PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
AFT PHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur AFT PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.01.Stablepharma Ltd: Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market333LONDON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Stablepharma Limited, specialists in thermostable formulations, today announced a development and option-to-license agreement with AFT Pharmaceuticals to develop...
► Artikel lesen
14.01.AFT PHARMACEUTICALS LIMITED: December Quarter FY 2026 Investor Update1
20.11.25Health Check: AFT Pharmaceuticals girds for major iron deficiency therapy trial1
20.11.25AFT Pharmaceuticals jumps +10% on $115M interim FY26 record revenue1
20.11.25AFT Pharma unveils record revenues of $115 million on global expansion1
AFT PHARMACEUTICALS Aktie jetzt für 0€ handeln
19.11.25AFT PHARMACEUTICALS LIMITED: AFT delivers 10th consecutive first half revenue increase2
18.11.25AFT PHARMACEUTICALS LIMITED: AFT CFO Malcolm Tubby to retire Simon Bosley CFO Designate-
18.11.25AFT PHARMACEUTICALS LIMITED: AFT CFO Malcolm Tubby to retire; Simon Bosley CFO Designate1
27.10.25Listen: From the Wire - AFT Pharmaceuticals CEO and Founder Hartley Atkinson2
23.10.25AFT PHARMACEUTICALS LIMITED: AFT to announce half year interim results Nov 20-
25.09.25AFT Pharma: FY27 revenue expected to hit $300M, positive iron IV results in2
24.09.25AFT PHARMACEUTICALS LIMITED: September Quarter FY2026 Investor Update-
01.09.25AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes-
01.09.25AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Int-
04.08.25AFT PHARMACEUTICALS LIMITED: Results of 2025 Annual Shareholder Meeting-
01.08.25AFT Pharmaceuticals outlines shareholder value focus in 2025 AGM1
31.07.25AFT PHARMACEUTICALS LIMITED: AFT ASM Chairs Speech-
31.07.25AFT PHARMACEUTICALS LIMITED: AFT ASM Presentation-
31.07.25AFT PHARMACEUTICALS LIMITED: AFT ASM Release-
31.07.25AFT PHARMACEUTICALS LIMITED: 2025 ASM Release, Chairs address & presentation-
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1